Item 7.01 Regulation FD Disclosure

On March 29 and 30, 2022, management of Hims & Hers Health, Inc., including Andrew Dudum, Chief Executive Officer, Yemi Okupe, Chief Financial Officer, and Jay Spitzer, Senior Vice President of Investor Relations, will conduct meetings with members of the investment community as part of a non-deal roadshow. A copy of the related investor presentation is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K, including the exhibit referenced herein, is being furnished under Item 7.01 and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. Such information shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein.

© Edgar Online, source Glimpses